New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
07:20 EDTCNATConatus Pharmaceuticals price target lowered to $14 from $16 at Stifel
Stifel cut its price target on Conatus as the firm thinks the extension of P2b ACLF data timelines due to slower than expected enrollment is negative. However, the firm keeps a Buy rating on the stock.
News For CNAT From The Last 14 Days
Check below for free stories on CNAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
08:59 EDTCNATConatus should be bought ahead of data, says JMP Securities
Subscribe for More Information
September 3, 2014
05:33 EDTCNATConatus management to meet with JMP Securities
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use